The Global Medtech Industry: Rewiring Medtech in a Post-Pandemic World
The medtech industry is undergoing rapid change to address evolving global market dynamics. This has been further accelerated by the pandemic. This white paper from IQVIA – an associate member of AdvaMed® – discusses how global markets and specific therapeutic areas are poised for growth over the next decade. Read this white paper to help inform business strategy.
Related Reading
Event / Global & Trade / Regulatory Affairs
Entering the Japanese Medical Device Market: Regulatory Pathways, Consultation Opportunities, and Practical Insights
September 1, 2026 |
7:00 PM – 8:30 PM ET
September 2, 2026 |
8:00 AM – 9:30 AM JST
Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.
Resource / AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Tariffs
AdvaMed® Advancements: Q2 2026 Report
July 14, 2026
Explore AdvaMed’s Q2 2026 Report to see how advocacy, member engagement, and policy progress are advancing innovation and strengthening the medtech industry.
Global & Trade
AdvaMed® Resources for Venezuelan Earthquake Response
Learn how AdvaMed® member companies can support earthquake relief efforts in Venezuela through medical supply donations, logistics assistance, financial contributions, and other humanitarian response initiatives.
Global & Trade
Support for Medical Supply and Equipment Needs in Namibia
Review Namibia’s current medical device and equipment needs and learn how interested companies can provide support for medical supply and equipment needs in Namibia.
Resource / China / Global & Trade / Regulatory Affairs / Standards
China GMP and ISO 13485: A Side-by-Side Comparison
June 22, 2026
China GMP and ISO 13485: A Side-by-Side Comparison
Blog / Emerging Policy Response Resources / Global & Trade / Tariffs
IEEPA Tariff Refunds Summary – What MedTech Companies Need to Know
April 29, 2026
After the Supreme Court struck down IEEPA tariffs, CBP launched the CAPE system to process refunds. Here’s what importers need to know about eligibility, submission, and timing.
Resource / AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Tariffs
AdvaMed® Advancements: Q1 2026 Report
April 24, 2026
Explore AdvaMed®’s Q1 2026 report on medtech policy, regulatory trends, reimbursement, and advocacy driving innovation and patient access.
Event / Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Supply Chain / Tariffs
IEEPA Tariff Refunds Are Coming: What Medtech Needs to Know
Now On-Demand
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.